MEDTECH INDUSTRY INVITED TO NSW PARLIAMENT HOUSE Local manufacturing emerges as key priority, along with jobs, supply chain resilience and patient benefits
With
Justin Foster,
Associate Director, Advocacy and Government Relations,
Medical Technology Association of Australia
Brendan Cummins
VP & General Manager ANZ,
Baxter Healthcare
The Hon Courtney Houssos MLC, Minister for Finance,
Minister for Domestic Manufacturing and Government Procurement,
Minister for Natural Resources, NSW Parliament
James Doyle, Vice-Chair
Medical Technology Association of Australia (MTAA)
Lachlan Thorpe, Age 21
Diagnosed with CRPS following sporting injury, recipient of spinal cord stimulator
SEGMENT
Filmed in Sydney | August 2026
The inaugural NSW Parliament MedTech Showcase, hosted by The Hon Courtney Houssos MLC has highlighted the medical technology sector’s contribution to patient care, local manufacturing, jobs and the broader economy.
Speaking with the Australian Health Journal, Justin Foster, Associate Director of Advocacy and Government Relations at the Medical Technology Association of Australia (MTAA), said the event provided an important opportunity for industry and government to work together on shared priorities.
He said the showcase demonstrated that MedTech not only saves and improves lives, but also creates significant economic opportunities through manufacturing, investment, exports and employment. “We’re collaborating with them on a unity ticket in terms of delivering more value to the economy, manufacturing, and also to local jobs,” Foster said.
The event brought together a diverse range of companies, from emerging startups and small and medium-sized businesses to global MedTech companies investing in NSW. The showcase also demonstrated the importance of sovereign manufacturing capability, particularly during supply disruptions.
The message was local production could strengthen supply chains while supporting highly skilled employment and innovation. The event also provided an opportunity for the industry to discuss policy issues, including value-based procurement, which seeks to ensure purchasing decisions consider the broader value of medical technologies rather than price alone.
Foster said the showcase could serve as a model for further engagement across Australia. “There is definitely an opportunity for us to be engaging across states and territories,” with future discussions potentially extending the initiative beyond NSW.
Source: Written by Australian Health Journal from transcript.
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.
-
Mid-Career Nurse Leadership Program
How does a nurse navigate senior management to affect change within their organisation? It’s a gap that Australian College of Nursing is helping to fill with it’s Mid-Career Nurse Leadership Program that gives established nursing professional access to prominent leaders in nursing.
-
Jack Lancaster, Evolution Surgical
Continuing the Australian Health Journal, People In Health Care series is Jack Lancaster, the CEO of Evolution Surgical, an Australian owned company established in 2014, specialising in spinal fusion implants and custom instrumentation.
Jack talks about how the company works closely with surgeons to design custom solutions manufactured to surgical requirements, and ultimately, to the benefit of the Australia patient.
